老年糖尿病患者血糖标志物与全因死亡风险的ARIC研究
该研究基于ARIC队列5636名66-90岁老年人,评估HbA1c、果糖胺、糖化白蛋白和空腹血糖与全因死亡风险的关联。中位随访6年发生983例死亡,在糖尿病患者中高HbA1c、果糖胺、糖化白蛋白和空腹血糖均与死亡风险增加相关,低HbA1c和低空腹血糖的关联在进一步调整后不再显著。研究支持在老年糖尿病患者中临床使用HbA1c。
要点
- 老年糖尿病患者中高HbA1c(≥64 mmol/mol)与死亡风险增加相关(HR 1.81)。
- 果糖胺、糖化白蛋白和空腹血糖升高也与死亡风险增加相关。
- 低HbA1c和低空腹血糖的死亡风险关联可能受健康状况混杂影响。
核心结论
- 在老年糖尿病患者中,升高的HbA1c、果糖胺、糖化白蛋白和空腹血糖与死亡风险相关。
- 低HbA1c和低空腹血糖可能是不良预后的标志,但可能受健康状况混杂。
- 研究结果支持在老年糖尿病患者中临床使用HbA1c。
研究设计与样本
- ARIC研究的前瞻性分析,纳入5636名66-90岁参与者,基线2011-2013年。
- 31%患有确诊糖尿病,平均年龄76岁,58%女性,21%黑人。
- 采用Cox回归分析血糖标志物(分类变量)与死亡风险的关联,按糖尿病状态分层。
主要发现
- 中位随访6年期间发生983例死亡。
- 糖尿病患者中,30%HbA1c低(<42 mmol/mol [<6.0%]),10%HbA1c高(≥64 mmol/mol [≥8.0%])。
- 人口学调整后,与HbA1c 42-52 mmol/mol(6.0-6.9%)相比,低HbA1c的HR为1.32(95% CI 1.04, 1.68),高HbA1c的HR为1.86(95% CI 1.32, 2.62)。
- 进一步调整生活方式和临床危险因素后,高HbA1c的HR为1.81(95% CI 1.28, 2.56),果糖胺的HR为1.96(95% CI 1.43-2.69),糖化白蛋白的HR为1.81(95% CI 1.33-2.47),空腹血糖的HR为1.81(95% CI 1.24, 2.66)。
- 低HbA1c和低空腹血糖在进一步调整后与死亡风险的关联不再显著。
临床怎么用
- 在老年糖尿病患者中,高HbA1c、果糖胺、糖化白蛋白和空腹血糖升高应视为死亡风险增加的标志。
- 低HbA1c和低空腹血糖可能提示不良预后,但需考虑健康状况混杂,不宜简单作为治疗不足的依据。
- HbA1c在老年糖尿病患者中具有临床实用价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: There is controversy regarding the performance of HbA1c in old age. We evaluated the prognostic value of HbA1c and other glycaemic markers (fructosamine, glycated albumin, fasting glucose) with mortality risk in older adults (66-90 years). METHODS: This was a prospective analysis of 5636 participants (31% with diagnosed diabetes, mean age 76, 58% female, 21% black) in the Atherosclerosis Risk in Communities (ARIC) study, baseline 2011-2013. We used Cox regression to examine associations of glycaemic markers (modelled in categories) with mortality risk, stratified by diagnosed diabetes status. RESULTS: During a median of 6 years of follow-up, 983 deaths occurred. Among older adults with diabetes, 30% had low HbA1c (<42 mmol/mol [<6.0%]) and 10% had high HbA1c (≥64 mmol/mol [≥8.0%]); low (HR 1.32 [95% CI 1.04, 1.68]) and high (HR 1.86 [95% CI 1.32, 2.62]) HbA1c were associated with mortality risk vs HbA1c 42-52 mmol/mol (6.0-6.9%) after demographic adjustment. Low fructosamine and glycated albumin were not associated with mortality risk. Both low and high fasting glucose were associated with mortality risk. After further adjustment for lifestyle and clinical risk factors, high HbA1c (HR 1.81 [95% CI 1.28, 2.56]), fructosamine (HR 1.96 [95% CI 1.43-2.69]), glycated albumin (HR 1.81 [95% CI 1.33-2.47]) and fasting glucose (HR 1.81 [95% CI 1.24, 2.66]) were associated with mortality risk. Low HbA1c and fasting glucose were no longer significantly associated with mortality risk. Among participants without diabetes, associations of glycaemic markers with mortality risk were less robust. CONCLUSIONS/INTERPRETATION: Elevated HbA1c, fructosamine, glycated albumin and fasting glucose were associated with risk of mortality in older adults with diabetes. Low HbA1c and fasting glucose may be markers of poor prognosis but are possibly confounded by health status. Our findings support the clinical use of HbA1c in older adults with diabetes. Graphical abstract.
引用
- Rooney MR, Tang O, Pankow JS, et al. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia. 2020. PMID: 32990802. doi:10.1007/s00125-020-05285-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。